Cargando…
Percutaneous endoscopic ventral facetectomy: An innovative substitute of open decompression surgery for lateral recess stenosis surgical treatment?
BACKGROUND: Percutaneous transforaminal endoscopic surgery (PTES) constitutes an innovative method principally recruited for the treatment of lumbar disc herniation. Indication spectrum of PTES is constantly widened in current years. Hence, PTES has been proposed to represent a satisfactory alternat...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187905/ https://www.ncbi.nlm.nih.gov/pubmed/30443139 http://dx.doi.org/10.4103/jcvjs.JCVJS_76_18 |
_version_ | 1783363112787771392 |
---|---|
author | Kapetanakis, Stylianos Gkantsinikoudis, Nikolaos Papathanasiou, Jannis V Charitoudis, Georgios Thomaidis, Tryfon |
author_facet | Kapetanakis, Stylianos Gkantsinikoudis, Nikolaos Papathanasiou, Jannis V Charitoudis, Georgios Thomaidis, Tryfon |
author_sort | Kapetanakis, Stylianos |
collection | PubMed |
description | BACKGROUND: Percutaneous transforaminal endoscopic surgery (PTES) constitutes an innovative method principally recruited for the treatment of lumbar disc herniation. Indication spectrum of PTES is constantly widened in current years. Hence, PTES has been proposed to represent a satisfactory alternative for the treatment of lateral recess stenosis (LRS), being defined as percutaneous endoscopic ventral facetectomy (PEVF) in these cases. The aim of this original study is to determine, for the first time in the literature, the outcomes of PEVF, especially in otherwise healthy nonelderly patients with LRS, alongside with special focus in health-related quality of life (HRQoL) assessment. MATERIALS AND METHODS: Eighty-five otherwise healthy individuals from 58 to 64 years were diagnosed with LRS, being subjected to successful PEVF. Patients were prospectively evaluated in 6 weeks, in 3, 6, and 12 months, and in 2 years postoperatively. Visual analog scales (VASs) were separately utilized for leg and low back pain evaluation (VAS-LP and VAS-BP, respectively), whereas Short Form-36 (SF-36) questionnaire was sequentially implemented for HRQoL assessment. RESULTS: All indexes of SF-36 as well as VAS-LP featured maximal amelioration in 6 weeks postoperatively, with subsequent further enhancement until 3 months and successor stabilization until 2 years. In contrast, VAS-BP presented minimal quantitative amelioration in 6 weeks, featuring no additional alterations. Values of all indexes in all follow-up intervals were demonstrated to be statistically significant in comparison with preoperative values (P < 0.05). No remarkable differentiation was observed between distinct parameters of SF-36. CONCLUSIONS: PEVF implementation in nonelderly patients with LRS was displayed to be safe and effective, providing alongside considerable improvement in HRQoL 2 years postoperatively. |
format | Online Article Text |
id | pubmed-6187905 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-61879052018-11-15 Percutaneous endoscopic ventral facetectomy: An innovative substitute of open decompression surgery for lateral recess stenosis surgical treatment? Kapetanakis, Stylianos Gkantsinikoudis, Nikolaos Papathanasiou, Jannis V Charitoudis, Georgios Thomaidis, Tryfon J Craniovertebr Junction Spine Original Article BACKGROUND: Percutaneous transforaminal endoscopic surgery (PTES) constitutes an innovative method principally recruited for the treatment of lumbar disc herniation. Indication spectrum of PTES is constantly widened in current years. Hence, PTES has been proposed to represent a satisfactory alternative for the treatment of lateral recess stenosis (LRS), being defined as percutaneous endoscopic ventral facetectomy (PEVF) in these cases. The aim of this original study is to determine, for the first time in the literature, the outcomes of PEVF, especially in otherwise healthy nonelderly patients with LRS, alongside with special focus in health-related quality of life (HRQoL) assessment. MATERIALS AND METHODS: Eighty-five otherwise healthy individuals from 58 to 64 years were diagnosed with LRS, being subjected to successful PEVF. Patients were prospectively evaluated in 6 weeks, in 3, 6, and 12 months, and in 2 years postoperatively. Visual analog scales (VASs) were separately utilized for leg and low back pain evaluation (VAS-LP and VAS-BP, respectively), whereas Short Form-36 (SF-36) questionnaire was sequentially implemented for HRQoL assessment. RESULTS: All indexes of SF-36 as well as VAS-LP featured maximal amelioration in 6 weeks postoperatively, with subsequent further enhancement until 3 months and successor stabilization until 2 years. In contrast, VAS-BP presented minimal quantitative amelioration in 6 weeks, featuring no additional alterations. Values of all indexes in all follow-up intervals were demonstrated to be statistically significant in comparison with preoperative values (P < 0.05). No remarkable differentiation was observed between distinct parameters of SF-36. CONCLUSIONS: PEVF implementation in nonelderly patients with LRS was displayed to be safe and effective, providing alongside considerable improvement in HRQoL 2 years postoperatively. Medknow Publications & Media Pvt Ltd 2018 /pmc/articles/PMC6187905/ /pubmed/30443139 http://dx.doi.org/10.4103/jcvjs.JCVJS_76_18 Text en Copyright: © 2018 Journal of Craniovertebral Junction and Spine http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Kapetanakis, Stylianos Gkantsinikoudis, Nikolaos Papathanasiou, Jannis V Charitoudis, Georgios Thomaidis, Tryfon Percutaneous endoscopic ventral facetectomy: An innovative substitute of open decompression surgery for lateral recess stenosis surgical treatment? |
title | Percutaneous endoscopic ventral facetectomy: An innovative substitute of open decompression surgery for lateral recess stenosis surgical treatment? |
title_full | Percutaneous endoscopic ventral facetectomy: An innovative substitute of open decompression surgery for lateral recess stenosis surgical treatment? |
title_fullStr | Percutaneous endoscopic ventral facetectomy: An innovative substitute of open decompression surgery for lateral recess stenosis surgical treatment? |
title_full_unstemmed | Percutaneous endoscopic ventral facetectomy: An innovative substitute of open decompression surgery for lateral recess stenosis surgical treatment? |
title_short | Percutaneous endoscopic ventral facetectomy: An innovative substitute of open decompression surgery for lateral recess stenosis surgical treatment? |
title_sort | percutaneous endoscopic ventral facetectomy: an innovative substitute of open decompression surgery for lateral recess stenosis surgical treatment? |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187905/ https://www.ncbi.nlm.nih.gov/pubmed/30443139 http://dx.doi.org/10.4103/jcvjs.JCVJS_76_18 |
work_keys_str_mv | AT kapetanakisstylianos percutaneousendoscopicventralfacetectomyaninnovativesubstituteofopendecompressionsurgeryforlateralrecessstenosissurgicaltreatment AT gkantsinikoudisnikolaos percutaneousendoscopicventralfacetectomyaninnovativesubstituteofopendecompressionsurgeryforlateralrecessstenosissurgicaltreatment AT papathanasioujannisv percutaneousendoscopicventralfacetectomyaninnovativesubstituteofopendecompressionsurgeryforlateralrecessstenosissurgicaltreatment AT charitoudisgeorgios percutaneousendoscopicventralfacetectomyaninnovativesubstituteofopendecompressionsurgeryforlateralrecessstenosissurgicaltreatment AT thomaidistryfon percutaneousendoscopicventralfacetectomyaninnovativesubstituteofopendecompressionsurgeryforlateralrecessstenosissurgicaltreatment |